Mumbai: GlaxoSmithKline (GSK) Pharmaceuticals on Monday announced its revenue from operations moved up to Rs 825.35 crore during October to December 2018 as compared to Rs 703.91 crore in the last corresponding period.
At the same time, the pharma major told stock exchange in a filing that the company’s net profit jumped to Rs 112.97 crore in Q3 of FY 2018-19. During Q3 of FY 2017-18, it was Rs 89.69 crore.
GlaxoSmithKline Pharmaceuticals business has been serving healthcare needs in India for more than 90 years. It has a wide range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease, and respiratory diseases.